Treatment with ICs causes a significant decrease in podocyte proliferation. by George Haddad (470789)

Detailed treatment status of people who received non- pharmacological treatment at first diagnosis. by Mingee Choi (15250732)

Subjects:

Regenerating axons are increased by ATRA and decreased by clodronate. by Valeria De La Rosa-Reyes (6658613)

“…Compared to PBS-treated, the number of regenerating axons is doubled by ATRA treatment, decreased by 30% by clodronate, and, in the case of ATRA combined with clodronate, is not significantly different.…”

Treatment at first diagnosis of insomnia disorder (%). by Mingee Choi (15250732)

Subjects:

Detailed treatment status of patients who did not receive non-pharmacological treatment at first diagnosis but received it later. by Mingee Choi (15250732)

Subjects:

Significant decrease of the viability of A375 melanoma cells after CD treatment. by Lena Berning (7430117)

Increasing gaps and decreasing returns attenuate spending effects. by William Minozzi (8564712)

<i>Nampt</i> expression is significantly decreased in primary hepatocytes after ethanol treatment. by Xiwen Xiong (442078)

Distribution of non-pharmacological treatment related to insomnia disorder (2002–2019). by Mingee Choi (15250732)

Subjects:

Mean interval from initial diagnosis to initiation of non-pharmacological treatment by year. by Mingee Choi (15250732)

Subjects:

Annual incidence of insomnia disorder (ICD-CODE: G47) Bar: rate of insomnia disorder relative to all patients; Line: average number of outpatient visits for patients with insomnia... by Mingee Choi (15250732)

Subjects:

General information of patient who diagnosis insomnia disorder (N = 518,119). by Mingee Choi (15250732)

Subjects:

Laser irradiation in the PBMT group. by Katayoon Montazeri (18389243)

Subjects:

Between-groups comparison of GIN and PPI values in control, tinnitus and PBMT groups. by Katayoon Montazeri (18389243)

Subjects:

Mean±SD of BTT and threshold in control, tinnitus and PBMT groups. by Katayoon Montazeri (18389243)

Subjects:

Diagram of methods. by Katayoon Montazeri (18389243)

Subjects:

Doublecortin (DCX) expression in 3 brain regions (coronal sections) in the control (Cont), Tinnitus (TIN) and PBMT (PBMT) groups. by Katayoon Montazeri (18389243)

Subjects:

PBMT parameters. by Katayoon Montazeri (18389243)

Subjects:

Fig 4 - by Katayoon Montazeri (18389243)

Subjects:

Bar graphs of DCX expression evaluated in three brain regions in the control (Cont), Tinnitus (TIN) and PBMT (PBMT) groups. by Katayoon Montazeri (18389243)

Subjects: